Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Lm Poon

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2026
Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025Samuel Ms Cheng, Nancy Hl Leung, Eunice Y Shiu, et al.
Nature Communications|August 23, 2025
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adultsCarolyn A Cohen, Ludivine Grzelak, Susan S Chiu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 6, 2022
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022Samuel Ms Cheng, Chris Ka Pun Mok, Karl Ck Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionCarolyn A Cohen, Athena Py Li, Asmaa Hachim, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 10, 2025
Detection and characterisation of high pathogenicity avian influenza virus (H5N1/H5N8) clade 2.3.4.4b, Hong Kong SAR, China, 2021 to 2024Wanying Sun, Ka Tim Choy, Ka Man Cheng, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 9, 2022
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infectionSamuel Sm Cheng, Chris Kp Mok, John Kc Li, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 30, 2020
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020Ranawaka Apm Perera, Chris Kp Mok, Owen Ty Tsang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 13, 2026
Population immunity, post-vaccine and post-infection antibody responses to influenza A (H3N2) subclade J.2 and K (J.2.4.1) viruses, Hong Kong, 2025Samuel Ms Cheng, Nancy Hl Leung, Eunice Y Shiu, et al.
Nature Communications|August 23, 2025
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adultsCarolyn A Cohen, Ludivine Grzelak, Susan S Chiu, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|May 6, 2022
SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022Samuel Ms Cheng, Chris Ka Pun Mok, Karl Ck Chan, et al.
Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infectionCarolyn A Cohen, Athena Py Li, Asmaa Hachim, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 10, 2025
Detection and characterisation of high pathogenicity avian influenza virus (H5N1/H5N8) clade 2.3.4.4b, Hong Kong SAR, China, 2021 to 2024Wanying Sun, Ka Tim Choy, Ka Man Cheng, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 9, 2022
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infectionSamuel Sm Cheng, Chris Kp Mok, John Kc Li, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 30, 2020
Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020Ranawaka Apm Perera, Chris Kp Mok, Owen Ty Tsang, et al.
Pageof 2